Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subendometrial autologous PRP injection for recurrent implantation failure in IVF
IRCT20130115012146N11Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Feb 2025
- Modality
- Adoptive Cell Transfer → Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of autologous platelet-rich plasma in infertility and Recurrent Implantation Failure (RIF) (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Clinical pregnancy. Started Feb 2025; status: completed.
02
Drugs
autologous platelet-rich plasma
03
Conditions
infertilityRecurrent Implantation Failure (RIF)
Beyond the preview
Go deeper on IRCT20130115012146N11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130115012146N11.